
|Articles|February 23, 2007
Oncolytics Biotech Appoints Vice President, IP
Author(s)BioPharm International Editors
Oncolytics Biotech (Calgary, Canada, www.oncolyticsbiotech.com) has appointed Mary Ann Dillahunty as VP, Intellectual Property.
Advertisement
Oncolytics Biotech (Calgary, Canada,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
2
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
3
Accelerate Your Biologic with HEK Cell Lines
4
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
5




